National Health Investors, Inc. NHI
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.45% | 1.59% | 6.22% | 6.84% | -1.80% |
| Total Other Revenue | 90.94% | 144.85% | 101.39% | 86.22% | 40.98% |
| Total Revenue | 26.31% | 33.81% | 28.33% | 25.33% | 8.32% |
| Cost of Revenue | 106.42% | 205.78% | 125.29% | 91.14% | 39.42% |
| Gross Profit | 5.02% | 7.79% | 10.82% | 12.92% | 2.26% |
| SG&A Expenses | 40.50% | 28.37% | -1.20% | 30.62% | 27.62% |
| Depreciation & Amortization | 27.44% | 28.27% | 23.67% | 15.92% | 13.78% |
| Other Operating Expenses | -0.41% | -12.35% | -20.07% | 244.68% | 193.98% |
| Total Operating Expenses | 61.68% | 81.86% | 52.11% | 45.50% | 25.63% |
| Operating Income | -10.42% | -2.95% | 7.95% | 9.12% | -5.23% |
| Income Before Tax | 1,635.00% | 52.88% | 17.55% | -11.65% | 15.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,634.14% | 50.88% | 17.55% | -11.65% | 15.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -19.01% | 5.37% | 0.57% | -20.88% | 28.86% |
| Net Income | 1,614.82% | 50.52% | 17.38% | -11.75% | 15.14% |
| EBIT | -10.42% | -2.95% | 7.95% | 9.12% | -5.23% |
| EBITDA | 1.48% | 5.77% | 12.41% | 11.04% | 0.02% |
| EPS Basic | 1,558.88% | 45.04% | 11.00% | -16.50% | 5.47% |
| Normalized Basic EPS | -3.26% | -9.92% | 4.12% | 9.46% | -11.35% |
| EPS Diluted | 1,562.32% | 45.24% | 10.81% | -16.17% | 6.15% |
| Normalized Diluted EPS | -2.88% | -9.79% | 3.99% | 9.70% | -10.67% |
| Average Basic Shares Outstanding | 3.38% | 3.73% | 5.69% | 5.62% | 9.10% |
| Average Diluted Shares Outstanding | 2.98% | 3.58% | 5.82% | 5.39% | 8.27% |
| Dividend Per Share | 2.17% | 2.22% | 2.22% | 2.22% | 2.22% |
| Payout Ratio | -0.94% | -0.30% | -0.08% | 0.26% | -0.05% |